Medicines being bottled in a production facility

ABPI addresses reports of the UK restricting medicines exports

Reports have emerged in recent days that the UK has banned exports of medicines which could have been used to treat Covid-19 patients. Discourse between the European Union and vaccine manufacturers is growing on the continent too, around the apparently unequal distribution of vaccine doses, while the UK Prime Minister Boris Johnson said during a recent Downing Street press conference that he simply didn’t want border “restrictions” placed on medicines.

So, what is the truth? Are the UK restricting the exporting of medicines from the country?

No, is the short answer according to Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI).

Longer form, the answer is more to do with misunderstandings between what the UK Government is restricting, and what it is not.

Mr Torbett explained: “Global supply chains are absolutely vital in ensuring that manufacturers can get medicines and vaccines to people who need them, wherever they are in the world.

"The UK Government is not restricting exports by manufacturers of any medicine or vaccine.

"Parallel exporting – where a wholesaler buys medicines meant for patients in one country and sell on for a higher price to another country, potentially aggravating supply problems – is a completely different issue.

“Limiting some parallel exporting during a pandemic is a sensible decision and one which has been taken by a number of countries, including in the EU.”

And this is what the UK has been limiting - and has been doing for some time during the Covid-19 pandemic.

The UK has had published guidance to wholesalers on the list of medicines which are either limited or temporarily prohibited from being horded or exported from the UK due to domestic need. This is a list of products which has been in effect for over a year and is routinely updated as need, availability and demand change over time.

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all